🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Left Ventricular Reverse Remodeling Evaluation After Surgical Correction of Aortic Regurgitation

Recruitingn/aAges 18 Years - anyAllPetrovsky National Research Centre of Surgery
NCT06805253 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Investigators assume that surgical correction approach to functional mitral regurgitation during intervention for chronic aortic regurgitation in patients with severe enlargement of the left heart chambers influences reverse remodeling of the left ventricle (LV) in the postoperative period. It is suggested that functional mitral regurgitation (MR) provides supra-physiological left ventricle volume overload and this fact plays positive role in early-stage post-operative left ventricle volume and function recovery. LV volume, systolic and diastolic function will be monitored with echocardiography (EchoCG) along with life quality in patients with different grades of functional mitral regurgitation secondary to severe chronic aortic insufficiency after surgical treatment of aortic regurgitation.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age over 18 years * Planned primary elective surgery for chronic aortic regurgitation * Presence of functional mitral regurgitation * End-diastolic volume of the left ventricle \>= 250 ml Exclusion Criteria: * Infectious endocarditis * History of myocardial infarction * Indications on simultaneous myocardial revascularisation * Acute aortic regurgitation of any etiology * Previously diagnosed dilatation of the left ventricle, not associated with the development of aortic regurgitation * Long-term persistent or permanent form of atrial fibrillation * Pregnancy in the first 12 months after surgery * Simultaneous participation in other studies * Presence of implanted pacemakers * Refusal to sign informed consent * Acute coronary event diagnosed within 12 months after aortic valve surgery * Indications for resynchronization therapy or permanent right ventricular pacing in the first 12 months after aortic valve surgery * Re-do cardiac surgery for any reason within 12 months after aortic valve surgery
💊

What it tests

  • Not applicable - observational study
📍

Where

2 sites
Petrovsky National Research Center of Surgery
Moscow, Russia
Voronezh Regional Clinical Hospital No. 1
Voronezh, Russia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy